CSIMarket
 


Bluejay Diagnostics Inc   (BJDX)
Other Ticker:  
 

Bluejay Diagnostics Inc 's Quick Ratio

BJDX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 1.81 below Bluejay Diagnostics Inc average.

Within Medical Equipment & Supplies industry 79 other companies have achieved higher Quick Ratio than Bluejay Diagnostics Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 924 to 1175.

Explain Quick Ratio?
How much Cash & cash equivalents BJDX´s has?
What are BJDX´s Current Liabilities?


BJDX Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change 83.89 % 87.08 % 8.45 % -64.25 % -
Y / Y Cash & cash equivalent Change -61.8 % -66.75 % -60.4 % 334.09 % -
Quick Ratio MRQ 1.81 2.78 4.78 6.17 8.73
BJDX's Total Ranking # 1175 # 924 # 557 # 461 # 484
Seq. Current Liabilities Change 52.79 % 29.04 % -13.42 % 7.72 % 55.44 %
Seq. Cash & cash equivalent Change -0.46 % -24.79 % -32.95 % -23.89 % -13.38 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 80
Healthcare Sector # 552
Overall Market # 1175


Quick Ratio Statistics
High Average Low
15.66 6.69 0.51
(Jun 30 2022)   (Sep 30 2021)




Financial Statements
Bluejay Diagnostics Inc 's Current Liabilities $ 3 Millions Visit BJDX's Balance sheet
Bluejay Diagnostics Inc 's Cash & cash equivalent $ 5 Millions Visit BJDX's Balance sheet
Source of BJDX's Sales Visit BJDX's Sales by Geography


Cumulative Bluejay Diagnostics Inc 's Quick Ratio

BJDX's Quick Ratio for the trailling 12 Months

BJDX Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 83.89 % 87.08 % 8.45 % -64.25 % -
Y / Y Cash & cash equivalent TTM Growth -61.8 % -66.75 % -60.4 % 334.09 % -
Quick Ratio TTM 3.52 5.5 8.18 10.25 5.72
Total Ranking TTM # 984 # 803 # 3396 # 2502 # 574
Seq. Current Liabilities TTM Growth 52.79 % 29.04 % -13.42 % 7.72 % 55.44 %
Seq. Cash & cash equivalent TTM Growth -0.46 % -24.79 % -32.95 % -23.89 % -13.38 %


On the trailing twelve months basis Due to jump in Current Liabilities in the III Quarter 2023 to $2.80 millions, cumulative Quick Ratio decreased to 3.52 below the Bluejay Diagnostics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 80 other companies have achieved higher Quick Ratio than Bluejay Diagnostics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 803 to 984.

Explain Quick Ratio?
How much Cash & cash equivalents BJDX´s has?
What are BJDX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 81
Healthcare Sector # 565
Within the Market # 984


trailing twelve months Quick Ratio Statistics
High Average Low
10.25 6.64 3.52
(Dec 31 2022)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Glucotrack Inc   4.74 $ 6.888  Millions$ 1.454  Millions
Pulmonx Corporation  4.63 $ 94.945  Millions$ 20.485  Millions
Helius Medical Technologies inc   4.60 $ 6.596  Millions$ 1.435  Millions
Glaukos Corp  4.48 $ 300.857  Millions$ 67.147  Millions
The Beauty Health Company  4.44 $ 559.444  Millions$ 125.879  Millions
Clearpoint Neuro Inc   4.36 $ 24.342  Millions$ 5.589  Millions
Profound Medical Corp   4.12 $ 26.213  Millions$ 6.366  Millions
Nevro Corp   4.02 $ 320.258  Millions$ 79.743  Millions
Sensus Healthcare Inc   3.92 $ 20.487  Millions$ 5.231  Millions
Intuitive Surgical Inc   3.86 $ 6,475.700  Millions$ 1,676.400  Millions
Inovio Pharmaceuticals Inc   3.83 $ 167.473  Millions$ 43.711  Millions
Tela Bio Inc   3.80 $ 58.202  Millions$ 15.334  Millions
Star Equity Holdings Inc   3.78 $ 25.561  Millions$ 6.761  Millions
Anika Therapeutics Inc   3.75 $ 105.333  Millions$ 28.064  Millions
Treace Medical Concepts Inc   3.68 $ 122.163  Millions$ 33.154  Millions
Outset Medical Inc   3.66 $ 193.998  Millions$ 53.024  Millions
Logicmark Inc   3.47 $ 6.683  Millions$ 1.927  Millions
Lemaitre Vascular Inc   3.34 $ 97.018  Millions$ 29.029  Millions
Vivani Medical Inc   3.34 $ 24.821  Millions$ 7.433  Millions
Staar Surgical Company  3.31 $ 188.113  Millions$ 56.775  Millions
Zynex inc   3.17 $ 52.441  Millions$ 16.561  Millions
Beyond Air Inc   3.10 $ 38.642  Millions$ 12.454  Millions
Nephros Inc   3.05 $ 4.622  Millions$ 1.517  Millions
Si bone inc   2.98 $ 53.492  Millions$ 17.969  Millions
Neuroone Medical Technologies Corporation  2.97 $ 5.322  Millions$ 1.793  Millions
Delcath Systems Inc   2.90 $ 40.512  Millions$ 13.974  Millions
Inogen Inc   2.88 $ 138.040  Millions$ 48.009  Millions
Predictive Oncology Inc   2.86 $ 11.915  Millions$ 4.172  Millions
Catheter Precision Inc   2.74 $ 5.579  Millions$ 2.035  Millions
Asensus Surgical Inc   2.73 $ 33.089  Millions$ 12.123  Millions

Date modified: 2023-11-12T09:12:28+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com